AI assistant
Medpace Holdings, Inc. — Director's Dealing 2021
Sep 7, 2021
30442_dirs_2021-09-07_418f4972-ce34-4fc2-8e19-c2cebdedcf13.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medpace Holdings, Inc. (MEDP)
CIK: 0001668397
Period of Report: 2021-09-02
Reporting Person: BURWIG SUSAN E (Exec. VP, Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-09-02 | Common Stock | S | 55037 | $192.16 | Disposed | 14968 | Direct |
| 2021-09-03 | Common Stock | S | 7185 | $192.67 | Disposed | 7783 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2021.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $190.00 to $194.04. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $190.88 to $193.41. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.